NL-OMON41854已完成不适用
A single-center, randomized, double-blind, placebo-controlled, single ascending dose study to investigate the pharmacokinetics, pharmacodynamic effects, safety and tolerability of single doses of RO5459072 in healthy volunteers. - RO5459072 Single Ascending Dose Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy subjects
- •18 and 60 years of age, inclusive
- •BMI 18 - 30 kilogram/meter2
- •non smokers
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
进行中（未招募）
1 期
Oxytocin TrialMedDRA version: 20.0Level: LLTClassification code 10003805Term: AutismSystem Organ Class: 100000004873Autism Spectrum DisorderEUCTR2013-003067-59-ITAZIENDA OSPEDALIERA G. BROTZ30
已完成
不适用
A single-center, randomized, double-blind, placebo-controlled, parallel-group studie investigating the safety, tolerability and pharmacokinetics of single- and multiple-ascending subcutaneous doses of TA-46 in healthy volunteersAchondroplasia10083624dwarfismNL-OMON48911Therachon SAS102
招募中
不适用
A human trial to evaluate effects of ginsenoside fortified red ginseng on immune function and fatigue recoveryKCT0001647Dunsan Korean Medicine Hospital of Daejeon University52
尚未招募
不适用
A single-center, randomized, double-blind, placebo-controlled human trial to evaluate the effect of steamed Panax Ginseng extract on the improvement of blood glucose levelKCT0003494Dunsan Korean Medicine Hospital of Daejeon University52
招募中
1 期
A single-center, randomized, double-blind, placebo-controlled, dose escalation study to observe the safety and efficacy of catalpol tablets in Chinese healthy subjects.diabetesITMCTR1900002878The First Affiliated Hospital, Zhejiang University